In some animal experiments, it has been reported that GLP-1 may be effective in improving inflammation [27,28], postprandial hyperlipidemia [29,30], endothelial cell dysfunction [31], and oxidative stress [32], as well as protecting -cells [33,34]
Table 2 Additional long COVID-19 symptoms and mechanisms
So it can't be said for certain if his idea was right or wrong
2009: A study found that taking 1 gram of acetyl-L-carnitine twice daily for 6 months lowered systolic blood pressure by approximately 8 mmHg compared to baseline
The Dual GLP-1/Glucagon Agonist for Weight Loss and MASH Boehringer Ingelheim's dual GLP-1/glucagon agonist 18.7% weight loss in Phase 2, 83% MASH resolution, Phase 3 ongoing
So, how much is too much